Comparing radiofrequency treatment and corticosteroid injection for hip osteoarthritis pain
Official title: Continuous Radiofrequency in Hip Osteoarthritis Pain: A Protocol of a Randomized Clinical Trial
Run by University of Brasilia · NCT06221709 · Data updated 2026-11-12
This study is testing whether a new radiofrequency treatment works better than a steroid injection for relieving pain and improving movement in people with hip osteoarthritis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | University of Brasilia Academic / other |
| Locations | 1 site (Brasília, Federal District) |
| Status | Recruiting |
| Started | February 1, 2024 |
| Main results expected | August 31, 2026 |
| Study ends | April 30, 2027 |
| Registry record updated | January 24, 2024 |
| Trial ID | NCT06221709 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 18 and older with symptomatic unilateral hip osteoarthritis grades II and III, experiencing pain for more than six months.
✕Probably not a fit
Patients with specific exclusions such as radiculopathy, previous hip surgeries, or other significant medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial is designed to evaluate the effectiveness of Conventional Radiofrequency (CRF) treatment compared to intraarticular corticosteroid injection in managing pain and improving function in patients with hip osteoarthritis. The study will be conducted at Hospital SARAH in Brasília, utilizing a double-blinded, randomized approach to ensure unbiased results. Participants will undergo sedation or general anesthesia, and the procedures will be performed under fluoroscopic guidance to ensure accurate placement of the treatment. The trial aims to provide insights into the best pain management strategies for individuals suffering from this condition.
Why it matters
Potential benefit: If successful, this study could provide a more effective pain management option for patients with hip osteoarthritis.
How similar studies have gone: Other studies have shown promising results with similar approaches, indicating potential for success in this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals ≥ 18 years of age, with symptomatic unilateral hip osteoarthritis, grades II and III according to the Kellgreen and Lawrance classification, hip pain for more than six months (medial, anterior, anterolateral, and/or lateral region) will be included. Exclusion Criteria: * Individuals with radiculopathy and ipsilateral irradiation, osteonecrosis of the femoral head, previous arthroplasty on the hip to be studied or surgical scar that could lead to changes in the anatomy of the hip, cases of high dislocation of the hip, pain exclusively in the posterior region, symptomatic ipsilateral knee osteoarthritis, intra-articular infiltration of corticosteroids or hyaluronic acid in the hip for less than six months, patients with neurological diseases, peripheral neuropathy or psychiatric diseases, use of a pacemaker or Prothrombin Activity Time (INR) \> 3.
Where it's running
-
Rede Sarah Hospitais de Reabilitação
Brasília, Federal District, Brazil Recruiting
Study contacts
- Study coordinator: Gilvan F Vaz, MD
- Email: gilvanvaz@gmail.com
- Phone: 5561991527220
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PENG nerve block with different steroid and sedative combinations for hip surgery in adults 65 and older
This trial will see if adding different combinations of dexamethasone and dexmedetomidine to a PENG nerve block gives adults 65 and older longer and better pain relief after hip surgery.
-
PENG block versus combined lumbar and sacral erector spinae plane (ESP) blocks for pain after total hip replacement
This trial will test whether the PENG nerve block or a combined lumbar-plus-sacral ESP block gives better pain relief and reduces opioid use in adults aged 65 and older having elective total hip replacement.
-
Ceramic hip resurfacing vs total hip arthroplasty for hip OA
This trial tests whether ceramic hip resurfacing helps people with hip OA walk farther each day than a modern total hip replacement.
-
Dexmedetomidine during hip replacement to modulate nerves and inflammation
A randomized, placebo-controlled study tests whether intravenous dexmedetomidine given during spinal anesthesia with a PENG nerve block can help regulate the body's stress and inflammatory response and improve recovery after hip replacement.
-
Preoperative Fasting to Shape the Gut with Hip Replacement
This trial tests whether a 20-day preoperative fasting plan can lower inflammatory signals and broaden gut microbes in adults undergoing total hip arthroplasty.
-
Cryoneurolysis for Chronic Pain: 6- and 12-Month Outcomes in Routine Care
This study tests whether cryoneurolysis, done as part of standard care for people with chronic pain, leads to meaningful improvements over 6 to 12 months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.